Investors still cautious about antitrust scrutiny on Anthem-Cigna deal
The stock price for Cigna Corp. remained lethargic during trading Thursday, as another mega-merger of insurers complicated the Anthem deal and sparked antitrust concerns.
Health Care & Life Sciences
Articles
Lilly posts lackluster profit but boosts full-year forecast
Eli Lilly and Co.’s profits plunged 18 percent in the second-quarter but still easily beat the lowered expectations of Wall Street analysts.
Alzheimer’s trials offer little certainty for investors, patients
Shares of Eli Lilly and Co. stagnated in Wednesday morning trading as investors and patients wished that the effects of solanezumab were more pronounced. Rival Biogen offered muddy results from its own Alzheimer’s drug.
Indy-area woman charged with faking nursing license, cancer
Ashley Trent faces charges of forgery, deception, theft and practicing nursing without a license. She also is accused of forging letters from IU Health that claimed she had breast cancer.
Report ranks Indiana 32nd for child well-being
The national report found that more Indiana children have health insurance and fewer are abusing drugs and alcohol, but the state still dropped in the rankings due to improved results in other states.
Lilly faces moment of truth this week
The Indianapolis-based drugmaker on Wednesday will release new data from patients taking its Alzheimer’s drug that could show whether the drug has slowed the progression of their disease. That will show investors whether the 45 percent rise in Lilly’s stock price over the past year is justified.
Cook Pharmica to hire 70 workers to expand drug-making capacity
Cook Pharmica, a subsidiary of Bloomington-based medical device maker Cook Group, currently employs 575 workers who manufacture and package drugs for use in clinical trials or for sale on the market.
Obama orders hospitals to serve full-meal deals—and sparks a health care revolution
The plan by the Medicare program to require hospitals in Indianapolis and 74 other cities to accept one payment for joint replacement surgeries is a huge step in fixing the crazy prices and spending growth in health care.
St. Vincent to dangle health insurance deal to employers
The hospital system and a partner company have started meeting with health insurance brokers to pitch a program to save employers money by keeping workers and their families healthier.
Lilly partner Immunocore raises record $320 million
Immunocore Ltd., which this week achieved the biggest private fundraising by a European biotechnology firm in 10 years, plans to accelerate development of its cancer therapy using the money and seek expedited approval.
OrthoIndy tries urgent care to bring in more patients, cope with reform
The large practice of orthopedic surgeons is in the midst of spending $3.8 million over three years to open seven urgent care clinics specializing in orthopedic-related injuries.
Health care industry: Healthy Indiana Plan working smoothly
State enrollment in HIP 2.0 has climbed to nearly 290,000 participants, with about 60 percent of those people under age 40, according to state figures presented Thursday.
Indiana relaxes bird show ban imposed due to avian flu
Indiana officials who imposed a statewide ban on bird shows have dialed back the emergency rule, but the ban will still keep chickens, ducks and other birds out of August’s Indiana State Fair.
Customers of Anthem say ID theft proliferating
Anthem Inc.’s massive data breach reported early this year is now generating real cases of identity theft, according to allegations in a small but growing number of lawsuits filed across the country. But Anthem and the FBI say none of the stolen data has been sold on the black market.
After silence, IU Health and Anthem voice concerns over Chamber’s smoking scandal
With Anthem and IU Health so hot to trot their anti-smoking bona fides, it’s surprising their responses to The New York Times' stories about the U.S. Chamber of Commerce blocking anti-smoking policies overseas have been so tepid.
Lilly, partner sue Lupin over generic testosterone
Indianapolis-based Eli Lilly and Co. and Acrux DDS Pty Ltd. have filed a lawsuit against Lupin Pharmaceuticals Inc. for alleged infringement of patents that cover the testosterone treatment Axiron.
Clot risk in Lilly lung-cancer drug raises FDA concerns
The drug, known as necitumumab, improved patients’ overall chances of survival, yet people taking the medicine also experienced more risk, Food and Drug Administration staff said in a report Tuesday.
Obamacare shovels another $122M to Indiana insurers
The money, known as reinsurance payments, helped MDwise, Anthem, Humana, Assurant and the Physicians Health Plan of Northern Indiana keep a lid on their losses even as lots of new patients with expensive or untreated medical conditions migrated into the private insurance market.
Aetna-Humana deal could push Cigna to take Anthem offer
With Aetna Inc. and Humana Inc. agreeing to a $37 billion merger, pressure is mounting on the other major health insurers, including Cigna Corp. and Anthem Inc., to make their own deals.
Indiana’s medical research ‘trade deficit’
Indiana's life sciences companies are spending four times more on medical research than the state's hospitals, doctors and univerities are receiving from such companies for research projects. That means Indiana is missing out on more than $80 million a year.